Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Screening test for prostate cancer]

K Imai1, Y Kubota, H Yamanaka

  • 1Dept. of Urology, Gunma University School of Medicine, Japan.

Gan to Kagaku Ryoho. Cancer & Chemotherapy
|September 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Intervention of somatic mutational events in vivo by a germline defect at the adenine phosphoribosyltransferase locus.

Human genetics·1997
Same author

[Effects of alcohol on urate metabolism].

Nihon rinsho. Japanese journal of clinical medicine·1997
Same author

[A case report of renal cell carcinoma with bilateral adrenal metastases].

Hinyokika kiyo. Acta urologica Japonica·1997
Same author

An asymptomatic germline missense base substitution in the hypoxanthine phosphoribosyltransferase (HPRT) gene that reduces the amount of enzyme in humans.

Human genetics·1997
Same author

Generation and molecular characterisation of monoclonal IgG4 rheumatoid factor from a patient with rheumatoid arthritis.

Annals of the rheumatic diseases·1997
Same author

[How to select and use urate lowering agents for hyperuricemia].

Nihon rinsho. Japanese journal of clinical medicine·1996

Prostate cancer screening using prostate specific antigen (PSA) shows promise, but combining it with other methods improves detection. Research into age-specific PSA and PSA velocity aims to enhance screening effectiveness.

Area of Science:

  • Urology
  • Oncology
  • Medical Diagnostics

Background:

  • Prostate specific antigen (PSA), digital rectal examination (DRE), and transrectal ultrasonography (TRUS) are standard prostate cancer detection methods.
  • PSA offers excellent sensitivity and positive predictive value but has limitations, with 73% sensitivity at a 6 ng/ml cutoff.

Purpose of the Study:

  • To evaluate the effectiveness of combining screening modalities for improved prostate cancer detection rates.
  • To explore the utility of PSA in mass screening settings due to ease of blood sampling.
  • To investigate age-specific PSA and PSA velocity for enhancing PSA test sensitivity.

Main Methods:

  • Review of current prostate cancer screening modalities (PSA, DRE, TRUS).
  • Analysis of PSA sensitivity at a specific cutoff value (6 ng/ml).

Related Experiment Videos

  • Investigation into age-specific PSA and PSA velocity for improved diagnostic accuracy.

    • Main Results:

    • PSA demonstrates high sensitivity and positive predictive value compared to DRE and TRUS.
    • A PSA cutoff of 6 ng/ml yields 73% sensitivity, indicating room for improvement.
    • Combining screening modalities is recommended for general clinical practice to increase detection rates.

    Conclusions:

    • Mass screening for prostate cancer, particularly in Japan where prevalence is rising, should prioritize PSA due to its feasibility.
    • Further research into age-specific PSA and PSA velocity is crucial for enhancing screening sensitivity.
    • Well-designed pilot studies are essential to validate the significance of prostate cancer mass screening programs.